Free Trial
LON:SAR

Sareum (SAR) Share Price, News & Analysis

Sareum logo
GBX 16 -0.50 (-3.03%)
As of 04:13 AM Eastern

About Sareum Stock (LON:SAR)

Key Stats

Today's Range
16
16.50
50-Day Range
13.66
20.65
52-Week Range
11
32
Volume
3,158 shs
Average Volume
404,460 shs
Market Capitalization
£19.99 million
P/E Ratio
N/A
Dividend Yield
1.10%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter.

SAR Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Sareum Holdings Refocuses Strategy After SRA737 Licensing Termination
See More Headlines

SAR Stock Analysis - Frequently Asked Questions

Sareum's stock was trading at GBX 24.60 at the beginning of 2025. Since then, SAR shares have decreased by 35.0% and is now trading at GBX 16.

Sareum Holdings plc (LON:SAR) announced its earnings results on Tuesday, March, 25th. The company reported ($0.90) EPS for the quarter.

Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP) and Summit Therapeutics (SMMT).

Company Calendar

Last Earnings
3/25/2025
Today
8/07/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Financial Services
Current Symbol
LON:SAR
CIK
N/A
Fax
N/A
Employees
3,211
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (4.22)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£5.28 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-270.25%
Return on Assets
-113.80%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
4.22
Quick Ratio
10.37

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 1.45 per share
Price / Cash Flow
11.32
Book Value
GBX 2.61 per share
Price / Book
6.28

Miscellaneous

Outstanding Shares
124,928,001
Free Float
N/A
Market Cap
£20.49 million
Optionable
Not Optionable
Beta
-1.08
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (LON:SAR) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners